Connor Clark & Lunn Investment Management Ltd. Takes Position in CareTrust REIT, Inc. $CTRE

Key Points

• Connor Clark & Lunn Investment Management acquired 522,543 CareTrust REIT shares worth approximately $21.1 million, representing about 0.22% of the company. Institutional investors collectively own 87.77% of CTRE.
• CareTrust REIT reported quarterly EPS of $0.51, in line with estimates, and revenue of $161.35 million. Management projects fiscal 2026 EPS of $2.03–$2.06.
• CTRE pays a quarterly dividend of $0.39 per share, equal to an annualized $1.56 and a 3.9% yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $44.82, compared with a share price of $39.90.

Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of CareTrust REIT, Inc. (NYSE:CTRE - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 522,543 shares of the company's stock, valued at approximately $21,085,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.22% of CareTrust REIT as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CTRE. Capital Square LLC bought a new stake in CareTrust REIT in the second quarter valued at $3,525,000. Meiji Yasuda Asset Management Co Ltd. bought a new position in CareTrust REIT in the 2nd quarter worth $221,000. Compass Financial Management LLC bought a new position in CareTrust REIT in the 2nd quarter worth $34,000. Elevation Point Wealth Partners LLC purchased a new stake in shares of CareTrust REIT in the 2nd quarter worth about $580,000. Finally, Greenland Capital Management LP bought a new stake in shares of CareTrust REIT during the 2nd quarter valued at about $9,684,000. Hedge funds and other institutional investors own 87.77% of the company's stock.

CareTrust REIT Trading Up 0.6%

NYSE:CTRE opened at $39.90 on Wednesday. CareTrust REIT, Inc. has a one year low of $32.79 and a one year high of $43.62. The company's 50-day simple moving average is $40.55 and its 200 day simple moving average is $39.77. The firm has a market capitalization of $9.43 billion, a P/E ratio of 25.09, a PEG ratio of 1.56 and a beta of 0.75. The company has a debt-to-equity ratio of 0.27, a current ratio of 0.57 and a quick ratio of 0.57.

CareTrust REIT (NYSE:CTRE - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.51 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.51. CareTrust REIT had a net margin of 62.19% and a return on equity of 8.52%. The firm had revenue of $161.35 million during the quarter. CareTrust REIT has set its FY 2026 guidance at 2.030-2.060 EPS. As a group, analysts forecast that CareTrust REIT, Inc. will post 2.05 EPS for the current fiscal year.

CareTrust REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Tuesday, June 30th were given a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 3.9%. The ex-dividend date of this dividend was Tuesday, June 30th. CareTrust REIT's dividend payout ratio is 98.11%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CTRE shares. Raymond James Financial assumed coverage on shares of CareTrust REIT in a research note on Tuesday, June 16th. They issued an "outperform" rating and a $43.00 price target for the company. Zacks Research upgraded CareTrust REIT from a "strong sell" rating to a "hold" rating in a research note on Monday, May 25th. KeyCorp restated an "overweight" rating and set a $46.00 price target on shares of CareTrust REIT in a research report on Friday, May 29th. Mizuho set a $45.00 price target on CareTrust REIT in a research note on Friday, May 22nd. Finally, Citigroup reiterated a "market outperform" rating on shares of CareTrust REIT in a report on Wednesday, June 10th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $44.82.

CareTrust REIT Company Profile

CareTrust REIT, Inc is a real estate investment trust based in Deerfield Beach, Florida, specializing in the ownership, acquisition and management of net-leased healthcare properties. The company primarily focuses on seniors housing and post-acute care facilities, entering into long-term, triple-net lease agreements with leading operators in the skilled nursing, assisted living, memory care, inpatient rehabilitation and specialty hospital sectors. Through its portfolio, CareTrust REIT aims to provide investors with stable and predictable rental income while supporting the ongoing demand for quality healthcare real estate across the United States.

Since its initial public offering in September 2013, CareTrust REIT has pursued a disciplined acquisition strategy, targeting properties in primary and select secondary markets.

Want to see what other hedge funds are holding CTRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CareTrust REIT, Inc. (NYSE:CTRE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.